Recent News

• 12.17.2025 - Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
• 11.20.2025 - Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
• 09.04.2025 - Sol-Gel Announces Health Canada Approval of EPSOLAY®
• 09.04.2025 - Sol-Gel Announces Health Canada Approval of EPSOLAY®

Recent Filings

• 12.17.2025 - EX-99.1 EX-99.1
• 12.17.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.20.2025 - EX-99.1 EX-99.1
• 11.20.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors